Position in DNA
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$11,939,572
-$4,680,428 QoQ
Shares Held
1,947,728
-2.6% QoQ
Ownership
2.98%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Erste Asset Management GmbH holds $563,481,319 across 72 Biotechnology names. DNA ranks #11 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,704,900 | $91,506,767 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
160,210 | $83,865,128 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
2,968,945 | $64,604,243 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
57,209 | $44,201,961 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
91,958 | $41,062,925 | |
| 6 | MIRM |
Mirum Pharmaceuticals, Inc.
|
210,000 | $19,399,800 | |
| 7 | REPL |
Replimune Group, Inc.
|
2,120,000 | $16,218,000 | |
| 8 | STOK |
Stoke Therapeutics, Inc.
|
446,000 | $14,521,760 |
All Filings in DNA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,939,572 | 1,947,728 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $16,620,000 | 2,000,000 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $32,076,000 | 2,200,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $22,500,000 | 2,000,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,405,000 | 1,650,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,260,240 | 739,332 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,075,000 | 500,000 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||